Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10852) 10852
Newspaper Article (2578) 2578
Book Chapter (205) 205
Web Resource (56) 56
Magazine Article (45) 45
Book / eBook (40) 40
Trade Publication Article (19) 19
Newsletter (16) 16
Reference (4) 4
Dissertation (3) 3
Government Document (3) 3
Book Review (2) 2
Conference Proceeding (2) 2
Pamphlet (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8861) 8861
science & technology (8186) 8186
life sciences & biomedicine (7840) 7840
biological and medical sciences (5375) 5375
male (5301) 5301
medical sciences (5264) 5264
female (5138) 5138
neuromuscular diseases (3653) 3653
adult (3651) 3651
middle aged (3521) 3521
neurology (3158) 3158
neurosciences & neurology (2794) 2794
clinical neurology (2360) 2360
aged (2281) 2281
diseases of striated muscles. neuromuscular diseases (1853) 1853
neurosciences (1801) 1801
animals (1719) 1719
abridged index medicus (1700) 1700
neuromuscular agents - therapeutic use (1647) 1647
treatment outcome (1613) 1613
anesthesia (1607) 1607
pharmacology. drug treatments (1478) 1478
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (1459) 1459
botulinum toxins, type a - therapeutic use (1433) 1433
anesthesiology (1336) 1336
adolescent (1313) 1313
muscular dystrophy (1124) 1124
child (1098) 1098
research (1018) 1018
surgery (1014) 1014
nervous system (1013) 1013
patients (993) 993
clinical trials (977) 977
botulinum toxin (961) 961
care and treatment (951) 951
general anesthesia. technics. complications. neuromuscular blocking. premedication. surgical preparation. sedation (946) 946
neuromuscular agents - administration & dosage (943) 943
botulinum toxins, type a - administration & dosage (899) 899
disease (876) 876
pediatrics (867) 867
myasthenia gravis (810) 810
neuropharmacology (778) 778
medicine (760) 760
prospective studies (747) 747
time factors (704) 704
medicine & public health (702) 702
general & internal medicine (678) 678
anesthetics. neuromuscular blocking agents (656) 656
child, preschool (655) 655
retrospective studies (651) 651
analysis (644) 644
pain (625) 625
double-blind method (606) 606
electromyography (597) 597
proteins (595) 595
aged, 80 and over (593) 593
young adult (591) 591
gene therapy (586) 586
health aspects (583) 583
mice (575) 575
follow-up studies (553) 553
drug therapy (551) 551
mutation (551) 551
dose-response relationship, drug (543) 543
neuromuscular junctions (529) 529
amyotrophic lateral sclerosis (514) 514
medical research (504) 504
disease models, animal (464) 464
injections, intramuscular (462) 462
risk factors (462) 462
studies (460) 460
quality of life (447) 447
pharmacology & pharmacy (436) 436
drug dosages (435) 435
neuromuscular diseases - drug therapy (425) 425
muscles (421) 421
rehabilitation (417) 417
neuromuscular junction - drug effects (414) 414
rats (408) 408
research article (404) 404
fundamental and applied biological sciences. psychology (396) 396
infant (393) 393
myasthenia (393) 393
research & development--r&d (389) 389
pharmaceutical industry (388) 388
neuromuscular agents - adverse effects (367) 367
fda approval (366) 366
medicine, general & internal (364) 364
musculoskeletal system (359) 359
severity of illness index (359) 359
hospitals (356) 356
neuromuscular junction (340) 340
botulinum toxins, type a - adverse effects (336) 336
neurological disorders (334) 334
diagnosis (331) 331
science & technology - other topics (330) 330
chronic disease (329) 329
muscle, skeletal - drug effects (329) 329
multidisciplinary sciences (327) 327
myasthenia gravis - drug therapy (323) 323
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Online Resources - Online (5) 5
Baycrest Hospital - Stacks (2) 2
St. Michael's Hospital - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Online (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13507) 13507
German (123) 123
French (108) 108
Spanish (47) 47
Portuguese (39) 39
Russian (32) 32
Japanese (28) 28
Polish (19) 19
Italian (17) 17
Dutch (7) 7
Norwegian (7) 7
Romanian (6) 6
Danish (4) 4
Czech (3) 3
Hungarian (3) 3
Swedish (3) 3
Chinese (2) 2
Finnish (2) 2
Serbian (2) 2
Turkish (2) 2
Croatian (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications
by de Lera Ruiz, Manuel and Kraus, Richard L
Journal of medicinal chemistry, ISSN 0022-2623, 09/2015, Volume 58, Issue 18, pp. 7093 - 7118
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Neoplasms - metabolism | Respiratory Tract Diseases - metabolism | Cardiovascular Diseases - drug therapy | Humans | Voltage-Gated Sodium Channels - physiology | Epilepsy - metabolism | Biological Products - pharmacology | Respiratory Tract Diseases - drug therapy | Pain - metabolism | Neuromuscular Diseases - drug therapy | Pain - drug therapy | Voltage-Gated Sodium Channel Blockers - therapeutic use | Protein Subunits - physiology | Voltage-Gated Sodium Channel Blockers - chemistry | Biological Products - therapeutic use | Protein Subunits - genetics | Protein Structure, Tertiary | Voltage-Gated Sodium Channels - genetics | Cardiovascular Diseases - metabolism | Drug Industry | Clinical Trials as Topic | Neuromuscular Diseases - metabolism | Neoplasms - drug therapy | Biological Products - chemistry | Channelopathies - genetics | Animals | Channelopathies - drug therapy | Voltage-Gated Sodium Channel Blockers - pharmacology | Epilepsy - drug therapy | Ligands | Voltage-Gated Sodium Channels - chemistry | Protein Subunits - chemistry | Mutation | Ion Channel Gating | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Guidelines for treatment of autoimmune neuromuscular transmission disorders
by Skeie, G. O and Apostolski, S and Evoli, A and Gilhus, N. E and Illa, I and Harms, L and Hilton‐Jones, D and Melms, A and Verschuuren, J and Horge, H. W and European Federation of Neurological Societies
European journal of neurology, ISSN 1351-5101, 07/2010, Volume 17, Issue 7, pp. 893 - 902
myasthenia gravis | neuromuscular transmission disorders | Lambert–Eaton myasthenic syndrome | neuromyotonia | Lambert-Eaton myasthenic syndrome | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | MEDLINE | Evidence-Based Medicine - methods | Meta-Analysis as Topic | Humans | Isaacs Syndrome - therapy | Myasthenia Gravis - therapy | Autoimmune Diseases - immunology | Clinical Protocols - standards | Isaacs Syndrome - drug therapy | Evidence-Based Medicine - trends | Isaacs Syndrome - immunology | Lambert-Eaton Myasthenic Syndrome - immunology | Lambert-Eaton Myasthenic Syndrome - therapy | Neuromuscular Junction Diseases - drug therapy | Review Literature as Topic | Autoimmune Diseases - therapy | Neuromuscular Junction Diseases - therapy | Myasthenia Gravis - immunology | Neuromuscular Junction Diseases - immunology | Myasthenia Gravis - drug therapy | Autoimmune Diseases - drug therapy | Lambert-Eaton Myasthenic Syndrome - drug therapy | Viral antibodies | Medical colleges | Online health care information services | Myasthenia gravis | Corticosteroids | Immunotherapy | Practice guidelines (Medicine) | Antibodies | Drug therapy | Azathioprine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
by Benoy, Veronick and Vanden Berghe, Pieter and Jarpe, Matthew and Van Damme, Philip and Robberecht, Wim and Van Den Bosch, Ludo
Neurotherapeutics, ISSN 1933-7213, 04/2017, Volume 14, Issue 2, pp. 417 - 428
Charcot–Marie–Tooth disease | Acetylated α-tubulin | Compound screening | HSPB1 | Mitochondria | Histone deacetylase 6 | Pharmacology & Pharmacy | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Histone Deacetylase 6 - antagonists & inhibitors | Neuromuscular Junction - drug effects | Charcot-Marie-Tooth Disease - enzymology | Muscle, Skeletal - innervation | Axonal Transport - drug effects | Charcot-Marie-Tooth Disease - drug therapy | Pyrimidines - pharmacology | Animals | Pyrimidines - therapeutic use | Muscle, Skeletal - drug effects | Histone Deacetylase Inhibitors - pharmacology | Hydroxamic Acids - therapeutic use | Histone Deacetylase Inhibitors - therapeutic use | Mice | Tumor Cells, Cultured | Drug Evaluation, Preclinical | Ganglia, Spinal - drug effects | Neurons - drug effects | Hydroxamic Acids - pharmacology | Medicine, Experimental | Medical research | Tubulins | Analysis | Neurophysiology | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets
by Briston, Thomas and Selwood, David L and Szabadkai, Gyorgy and Duchen, Michael R
Trends in pharmacological sciences (Regular ed.), ISSN 0165-6147, 01/2019, Volume 40, Issue 1, pp. 50 - 70
cyclophilin D | calcium | drug discovery | mPTP | mitochondria | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Mitochondrial Membrane Transport Proteins - metabolism | Mitochondrial Membrane Transport Proteins - antagonists & inhibitors | Humans | Reperfusion Injury - drug therapy | Drug Discovery - methods | Mitochondria - metabolism | Molecular Targeted Therapy | Neurodegenerative Diseases - drug therapy | Neuromuscular Diseases - drug therapy | Neuromuscular Diseases - physiopathology | Animals | Neurodegenerative Diseases - physiopathology | Cell Death - physiology | Reperfusion Injury - physiopathology | Child | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Cytokine Therapies in Neurological Disease
by Azodi, Shila and Jacobson, Steven
Neurotherapeutics, ISSN 1933-7213, 7/2016, Volume 13, Issue 3, pp. 555 - 561
Neurology | Neurosciences | Biomedicine | Neurobiology | Cytokine | drug development | Neurosurgery | anticytokine | neurology | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cytokines - therapeutic use | Alzheimer Disease - complications | Humans | Nervous System Diseases - drug therapy | Alzheimer Disease - drug therapy | Demyelinating Diseases - complications | Stroke - complications | Treatment Outcome | Clinical Trials as Topic | Stroke - drug therapy | Nervous System Diseases - complications | Neuromuscular Diseases - drug therapy | Multiple Sclerosis - complications | Animals | Encephalitis - drug therapy | Neuromuscular Diseases - complications | Encephalitis - complications | Cytokines - antagonists & inhibitors | Demyelinating Diseases - drug therapy | Multiple Sclerosis - drug therapy | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text RNA-targeted drugs for neuromuscular diseases
by Ferlini, Alessandra and Goyenvalle, Aurelie and Muntoni, Francesco
Science (American Association for the Advancement of Science), ISSN 0036-8075, 01/2021, Volume 371, Issue 6524, pp. 29 - 31
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Gene Transfer Techniques | Exons | Humans | Morpholinos - therapeutic use | Oligonucleotides, Antisense - therapeutic use | Dynamin II - genetics | RNA Precursors - genetics | Dependovirus | Molecular Targeted Therapy | Muscular Dystrophy, Duchenne - therapy | RNA Stability | Genetic Therapy - methods | Drugs | Motor neurons | Neuromuscular diseases | Mental disorders | Peripheral nerves | Muscles | Viruses | Ribonucleic acid--RNA | Drug development | Skeletal muscle | Musculoskeletal system | Nerves | Neuromuscular junctions | Gene therapy | Index Medicus | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Emerging Issues in AAV-Mediated In Vivo Gene Therapy
by Colella, Pasqualina and Ronzitti, Giuseppe and Mingozzi, Federico
Molecular therapy. Methods & clinical development, ISSN 2329-0501, 03/2018, Volume 8, Issue C, pp. 87 - 104
genotoxicity | inherited diseases | AAV | liver immunogenicity | AAV genome | gene therapy | persistence | AAV capsid | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Antigens | Neuromuscular diseases | Disease | Neurodegenerative diseases | Clinical trials | Viruses | Infections | Genomes | Drug development | Vectors (Biology) | Proteins | Plasmids | Blindness | Conflicts of interest | Biomarkers | Gene therapy | Drug dosages | Deoxyribonucleic acid--DNA | Methods | Expression vectors | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights